Skip to main content
main-content

Features and expert interviews

Features and expert interviews

04-24-2019 | Type 2 diabetes | Feature | Article

Young-onset type 2 diabetes: A different process?

Escalating obesity prevalence and severity has led to type 2 diabetes being diagnosed in ever-younger people, including children. medwireNews rounds up the accumulating evidence suggesting a particularly severe diabetes course in these young people.

04-17-2019 | Nephropathy | Podcast | Article

Nephrologist expert commentary: The CREDENCE trial

Consultant nephrologist Andrew Frankel tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes (9:45).

04-17-2019 | Nephropathy | Podcast | Article

Primary care expert commentary: The CREDENCE trial

General practitioner Kevin Fernando talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective (4:43).

04-15-2019 | Nephropathy | Podcast | Article

Researcher comment: The CREDENCE trial

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice (6:51).

02-19-2019 | Artificial pancreas systems | Feature | Article

What’s all the fuss about the DIY artificial pancreas?

DIY closed-loop insulin delivery has provoked controversy within the diabetes community, raising questions around patient empowerment, safety and liability, and whether the regulatory process remains fit for purpose in a technological age. medwireNews takes a look at the issues.

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

11-16-2018 | Dapagliflozin | Feature | Video

Researcher comment: DECLARE-TIMI 58

DECLARE-TIMI 58 steering committee member John Wilding talks us through the trial's findings (5:49).

11-10-2018 | Dapagliflozin | Feature | Video

Expert commentary: DECLARE-TIMI 58

Miles Fisher talks to medwireNews about the results of the dapagliflozin cardiovascular outcomes trial DECLARE-TIMI 58.

09-30-2018 | UKPDS | Feature | Article

The UKPDS: A lasting legacy

Twenty years after the publication of the primary findings, medwireNews talks to longtime UKPDS investigator Professor David Matthews (University of Oxford, UK) about the struggles of the team to bring the trial to completion and the impact of the findings on diabetes care.

08-01-2018 | Type 2 diabetes | View from the clinic | Audio

Barriers to insulin: Management in type 2 diabetes patients

Editorial Board member Lori Berard discusses how to meet and overcome the challenges that follow the initial insulin prescription in patients with type 2 diabetes (11:53).

06-06-2018 | Insulin | View from the clinic | Audio

Barriers to insulin: Initiation in type 2 diabetes patients

Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy (9:00).

03-27-2018 | Inpatient diabetes | Feature | Article

The inpatient diabetes audit: A tool for change

With the 2017 NaDIA results showing some positive trends in inpatient diabetes care, medwireNews talks to national clinical lead Gerry Rayman about the tools and tactics to deliver the best patient outcomes.

03-19-2018 | Diet | View from the clinic | Audio

UK nutrition guidelines: A fresh approach

Board members John Wilding and Pamela Dyson talk about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines (9:43).

03-16-2018 | Obesity | Editorial | Video

The updated Diabetes UK nutrition guidelines: an obesity specialist’s view

John Wilding explains how the latest update of the nutrition guidelines will help clinicians working with patients with obesity (1:53).

03-16-2018 | Diet | Editorial | Video

What’s new in the Diabetes UK nutrition guidelines

Registered Dietitian Pamela Dyson explains why the latest update of the nutrition guidelines is an important departure from previous versions (0:45).

Talking point

Metabolically healthy obesity: Laying a controversial concept to rest

The concept of metabolically healthy obesity has produced huge numbers of seemingly contradictory studies, and polarized opinion among researchers. medwireNews looks back at the big data, the high-impact publications, and the underlying hypotheses that helped the concept to persist for so long, and asks if the field has finally reached consensus.

10-17-2017 | GLP-1 agonists | Feature | Article

GLP-1 receptor agonists: Cardiovascular trials and triumphs

With four GLP-1 receptor agonists now having published cardiovascular outcome data, medwireNews takes a look at how the experts are interpreting the conflicting findings, and what they mean for prescribing decisions.

09-08-2017 | SGLT2 inhibitors | Podcast | Audio

SGLT2 inhibitors: The story so far

Editorial board member John Wilding discusses the lessons for healthcare professionals from the SGLT2 inhibitor cardiovascular outcome trials about the benefits and drawbacks of the medication class (14:07).

08-22-2017 | Canagliflozin | Podcast | Audio

Dissecting the CANVAS trial

Listen to CANVAS investigators Carol Wysham and Lori Berard discussing the efficacy and safety findings of the trials (11:17).

03-21-2017 | Insulin pumps | Feature | Article

Adolescents: A challenging age group

Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.

Image Credits